Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trialStéphane Palfi, Kyriacos Mitrophanous, Jean Marc Gurruchaga et al.|The Lancet|2014Cited by 436
Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis ConsortiumKenneth Aldape, Nikolajs Zeps, Amanda Bates et al.|Neuro-Oncology|2018Cited by 202